A trifunctional peptide broadly inhibits SARS-CoV-2 Delta and Omicron variants in hamsters

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2056-5968
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
A trifunctional peptide broadly inhibits SARS-CoV-2 Delta and Omicron variants in hamsters ; volume:8 ; number:1 ; day:30 ; month:6 ; year:2022 ; pages:1-15 ; date:12.2022
Cell discovery ; 8, Heft 1 (30.6.2022), 1-15, 12.2022

Urheber
Zhao, Hanjun
To, Kelvin Kai-Wang
Lam, Hoiyan
Zhang, Chuyuan
Peng, Zheng
Meng, Xinjie
Wang, Xiankun
Zhang, Anna Jinxia
Yan, Bingpeng
Cai, Jianpiao
Yeung, Man Lung
Chan, Jasper Fuk-Woo
Yuen, Kwok-Yung
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1038/s41421-022-00428-9
URN
urn:nbn:de:101:1-2022082022264482317502
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:30 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Zhao, Hanjun
  • To, Kelvin Kai-Wang
  • Lam, Hoiyan
  • Zhang, Chuyuan
  • Peng, Zheng
  • Meng, Xinjie
  • Wang, Xiankun
  • Zhang, Anna Jinxia
  • Yan, Bingpeng
  • Cai, Jianpiao
  • Yeung, Man Lung
  • Chan, Jasper Fuk-Woo
  • Yuen, Kwok-Yung
  • SpringerLink (Online service)

Ähnliche Objekte (12)

A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge

A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge

A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants

A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants

Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2

Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2

Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters

Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters

Gossypol Broadly Inhibits Coronaviruses by Targeting RNA‐Dependent RNA Polymerases

Gossypol Broadly Inhibits Coronaviruses by Targeting RNA‐Dependent RNA Polymerases

Monovalent vaccination with inactivated SARS-CoV-2 BA.5 protects hamsters against Omicron but not non-Omicron variants

Monovalent vaccination with inactivated SARS-CoV-2 BA.5 protects hamsters against Omicron but not non-Omicron variants

Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages

Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages

Omicron infection enhances Delta antibody immunity in vaccinated persons

Omicron infection enhances Delta antibody immunity in vaccinated persons

ChAdOx1 nCoV-19 (AZD1222) or nCoV-19-Beta (AZD2816) protect Syrian hamsters against Beta Delta and Omicron variants

ChAdOx1 nCoV-19 (AZD1222) or nCoV-19-Beta (AZD2816) protect Syrian hamsters against Beta Delta and Omicron variants

Deep learning-based rapid generation of broadly reactive antibodies against SARS-CoV-2 and its Omicron variant

Deep learning-based rapid generation of broadly reactive antibodies against SARS-CoV-2 and its Omicron variant

Gossypol Broadly Inhibits Coronaviruses by Targeting RNA‐Dependent RNA Polymerases (Adv. Sci. 35/2022)

Gossypol Broadly Inhibits Coronaviruses by Targeting RNA‐Dependent RNA Polymerases (Adv. Sci. 35/2022)

PRO 2000, a broadly active anti-HIV sulfonated compound, inhibits viral entry by multiple mechanisms

PRO 2000, a broadly active anti-HIV sulfonated compound, inhibits viral entry by multiple mechanisms

Verbundene Objekte